Results 21 to 30 of about 4,854,757 (315)

Association of Clinical Outcomes With Left Ventricular Assist Device Use by Bridge to Transplant or Destination Therapy Intent: The Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) Randomized Clinical Trial.

JAMA Cardiol, 2020
Key Points Question In patients with advanced heart failure, do outcomes with left ventricular assist device implantation differ by the initial intended goal of therapy as a bridge to transplant or destination therapy?
Goldstein DJ, Naka Y, Horstmanshof D, Ravichandran AK, Schroder J, Ransom J, Itoh A, Uriel N, Cleveland JC, Raval NY, Cogswell R, Suarez EE, Lowes BD, Kim G, Bonde P, Sheikh FH, Sood P, Farrar DJ, Mehra MR.   +18 more
europepmc   +2 more sources

Left ventricular assist device implantation in high risk destination therapy patients: an alternative surgical approach [PDF]

Journal of Cardiothoracic Surgery, 2012
Left Ventricular Assist Device (LVAD) for Destination Therapy (DT) is an established therapy for end stage heart failure patients who are not transplant candidates.
Samuels Louis E, Casanova-Ghosh Elena, Rodriguez Roberto, Droogan Christopher   +3 more
doaj   +2 more sources

Effectiveness of an Intervention Supporting Shared Decision Making for Destination Therapy Left Ventricular Assist Device: The DECIDE-LVAD Randomized Clinical Trial.

JAMA Intern Med, 2018
Importance Shared decision making helps patients and clinicians elect therapies aligned with patients’ values and preferences. This is particularly important for invasive therapies with considerable trade-offs.
Allen LA, McIlvennan CK, Thompson JS, Dunlay SM, LaRue SJ, Lewis EF, Patel CB, Blue L, Fairclough DL, Leister EC, Glasgow RE, Cleveland JC, Phillips C, Baldridge V, Walsh MN, Matlock DD.   +15 more
europepmc   +2 more sources

Driveline Infection in Ventricular Assist Devices and Its Implication in the Present Era of Destination Therapy. [PDF]

Open J Cardiovasc Surg, 2017
Advances in mechanical circulatory support devices provided the technology to develop long-term, implantable left ventricular assist devices as bridge to transplant, destination therapy, and in a lesser group of patients, as bridge to recovery.
Hernandez GA, Breton JDN, Chaparro SV.
europepmc   +2 more sources

Heart transplantation versus left ventricular assist devices as destination therapy or bridge to transplantation for 1-year mortality: a systematic review and meta-analysis. [PDF]

Ann Cardiothorac Surg, 2018
Background The optimal treatment for advanced heart failure (HF) patients with regards to mortality remains unknown. Heart transplantation (HTx) and left ventricular assist devices (LVAD) used either as a bridge to transplant (BTT) or destination therapy
Theochari CA, Michalopoulos G, Oikonomou EK, Giannopoulos S, Doulamis IP, Villela MA, Kokkinidis DG.   +6 more
europepmc   +2 more sources

Destination Therapy Strategies of Advanced Heart Failure in Elderly Non-Heart Transplant Candidates: A Propensity Matching Analysis from the LEVO-D and REGALAD Registries [PDF]

Life
Heart transplantation (HT) is the gold standard therapy for advanced heart failure (ADHF), and LVADs as destination therapy are an option in non-HT candidates.
David Dobarro, Sergio Raposeiras-Roubin, Luis Almenar-Bonet, Eduard Solé-González, Mireia Padilla-Lopez, Carles Diez-Lopez, Javier Castrodeza, Maria Dolores García-Cosío, Marta Cobo-Marcos, Javier Tobar, Pau Codina, Silvia Lopez-Fernandez, Francisco Pastor, Diego Rangel-Sousa, Eduardo Barge-Caballero, Beatriz Diaz-Molina, Alfredo Barrio-Rodriguez, Virginia Burgos-Palacios, Jesús Álvarez-García, Oscar González-Fernández, Andrés Grau-Sepulveda, José Manuel Garcia-Pinilla, Sonia Ruiz-Bustillo, Ana B. Mendez-Fernández, David Vaqueriza-Cubillo, Igor Sagasti-Aboitiz, Miguel Rodriguez-Santamarta, Ainara Lozano-Bahamonde, Ana Abecia, Inés Gómez-Otero, Raquel Marzoa, Eva González-Babarro, Manuel Gómez-Bueno, José Gonzalez-Costello   +33 more
doaj   +2 more sources

An infectious disease perspective-is destination therapy a viable option for total artificial hearts? [PDF]

Ann Cardiothorac Surg, 2020
Zabner R, Lam LD, Runyan C.
europepmc   +3 more sources

Use of Impella 5.5 in patients with cardiogenic shock as a bridge to decision, recovery, or destination therapy

IHJ Cardiovascular Case Reports (CVCR), 2023
Anju Bhardwaj, Ismael A. Salas de Armas, Dina Al Rameni, M. Patel, M. Akay, B. Kar, I. Gregoric   +6 more
semanticscholar   +2 more sources

Mechanical circulatory support for destination therapy: why are we so late? [PDF]

Swiss Medical Weekly, 2016
Robert Guidoin
doaj   +2 more sources

Social Determinants of Health and Rates of Implantation for Patients Considering Destination Therapy Left Ventricular Assist Device. [PDF]

J Card Fail, 2021
Flint K, Chaussee EL, Henderson K, Breathett K, Khazanie P, Thompson JS, Mcilvennan CK, Larue SJ, Matlock DD, Allen LA.   +9 more
europepmc   +2 more sources